Stockscreener 앱 받기
1.07
1.90%
0.02
시간 외 거래:
1.04
-0.03
-2.80%
Scisparc Ltd 주식(SPRC)의 최신 뉴스
SciSparc receives Nasdaq notice over stockholders’ equity shortfall - MSN
Gainers Report: Is SciSparc Ltd backed by strong institutional buyingDollar Strength & AI Driven Price Predictions - baoquankhu1.vn
Short Covering: What drives SciSparc Ltd.’s stock price2025 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Form 424B5 SciSparc Ltd. - StreetInsider
SciSparc Receives Nasdaq Notice Over Minimum Stockholders’ Equity Non-Compliance - The Globe and Mail
SciSparc to acquire MUSE endoscopic system patents from Xylo By Investing.com - Investing.com Nigeria
SciSparc Moves Into Endoscopy With Strategic Patent Deal - Benzinga
SciSparc Ltd. (SPRC) stock: dips nearly 12% as company unveils strategic MUSE™ endoscopic technology acquisition - parameter.io
SciSparc Faces Nasdaq Non-Compliance Challenge Over Stockholders’ Equity - StocksToTrade
SciSparc to acquire MUSE endoscopic system patents from Xylo - Investing.com India
SciSparc Faces Nasdaq Noncompliance: Struggles Loom - StocksToTrade
SciSparc Launches $766,170 Registered Direct Share Offering - TipRanks
SciSparc to Acquire Endoscopic Device Patents Targeting $3B Market - Meyka
SciSparc Signs Agreement To Acquire Patent Portfolio For Endoscopic Technologies; Stock Soars - Nasdaq
SciSparc Subsidiary to Acquire Endoscopic Patents of Xylo Technologies in All-Stock Deal - marketscreener.com
SciSparc to Acquire Xylo GERD Device IP in Share-Based Deal, Targeting Global Endoscope Market - TipRanks
SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity - The Manila Times
About Us - FinancialContent
SciSparc receives Nasdaq non-compliance notice for stockholders’ equity By Investing.com - Investing.com Nigeria
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
SciSparc receives Nasdaq non-compliance notice for stockholders’ equity - Investing.com
SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance - The Manila Times
SciSparc Ltd. Receives Nasdaq Notification of Non-Compliance with Stockholders' Equity Requirement - Quiver Quantitative
Is SciSparc Ltd. stock oversold or undervaluedChart Signals & Low Drawdown Momentum Ideas - Улправда
Breakout Zone: How SciSparc Ltd stock benefits from global expansionJuly 2025 Intraday Action & Growth Focused Investment Plans - Bộ Nội Vụ
Published on: 2026-01-09 12:53:14 - Улправда
Why SciSparc Ltd. stock remains on watchlistsJuly 2025 WrapUp & Growth Focused Stock Reports - Улправда
Why SciSparc Ltd. stock is seen as undervalued2025 Market Sentiment & Growth-Oriented Investment Plans - Улправда
Neurothera Labs Announces Results of AGM - TheNewswire
VIX Spike: Why SciSparc Ltd. stock remains a top recommendationJuly 2025 Outlook & Free Fast Gain Swing Trade Alerts - Улправда
How strong is SciSparc Ltd. stock revenue growthMarket Sentiment Report & AI Enhanced Trading Alerts - Улправда
Why SciSparc Ltd. stock remains a top recommendation2025 Growth vs Value & Daily Chart Pattern Signals - Улправда
Can SciSparc Ltd. stock deliver strong Q4 earningsStop Loss Placement Tips & Small Investment Capital Tips - Улправда
SciSparc says Neurothera Labs granted patent by Israeli Patent Office - MSN
What drives SciSparc Ltd stock priceHigh Dividend Yield Stocks & Small Budget Capital Growth - Early Times
Libord Securities Limited Testing Reversal Zone on Weekly ChartMarket Sentiment Report & Outstanding Investment Returns - earlytimes.in
What analysts say about SciSparc Ltd stockStock Correlation Metrics & Daily Tips From Top Market Analysts - earlytimes.in
SciSparc Calls February 2026 Meeting to Approve New Deloitte Auditor and Executive Equity Awards - TipRanks
SciSparc’s subsidiary NeuroThera receives patent in Israel for opioid tech By Investing.com - Investing.com Nigeria
SciSparc’s subsidiary NeuroThera receives patent in Israel for opioid tech - Investing.com India
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects - The Manila Times
SciSparc Ltd.'s Majority-Owned NeuroThera Labs Receives Patent for Opioid-N-acylethanolamine Combination to Enhance Pain Management - Quiver Quantitative
SciSparc: Neurothera Labs Granted Patent by Israeli Patent - GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aug Catalysts: How SciSparc Ltd stock benefits from global expansionDividend Hike & High Accuracy Buy Signal Tips - moha.gov.vn
CEO Moves: Is Venture Global Inc. stock a good choice for value investorsJuly 2025 Trade Ideas & Risk Controlled Swing Alerts - moha.gov.vn
Aug Drivers: Is SciSparc Ltd stock oversold or undervaluedMarket Risk Summary & High Conviction Buy Zone Picks - moha.gov.vn
Market Wrap: Is SciSparc Ltd. stock oversold or undervaluedWeekly Gains Report & Verified Momentum Stock Ideas - moha.gov.vn
SciSparc (SPRC) Stock Price, Quote, News & History - Benzinga
4.73%
0.92%
자본화:
|
볼륨(24시간):